Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.

By M. Bent, D. Áfra, O. Witte, M. Hassel, S. Schraub, K. Hoang-Xuan, P. Malmström, L. Collette, M. Piérart, R. Mirimanoff and 1 more. The Lancet, 2005

946 citations recorded by the source corpus.

Subfields: Epidemiology, Genetics, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/7b41a9651a6a9e6ff5a2d4cb048fc62b41863ed6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Brada
2. J. Tonn
3. M. Bent
4. R. Stupp
5. G. Pentheroudakis
6. M. Davis

Citations in the corpus

• High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014, background): “In an exemplary randomised trial, investigators from the EORTC have demonstrated that an ‘expectative’ or cautious approach—delaying additional radiotherapy until symptoms prevail and the tumour has grown to >5–6 cm—will substantially delay or eliminate the need for irradiation in a significant numb”
• Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. (2012, neutral): “Time from image finding to diagnostic procedure, median (IQR), d 15 (9-35) 35 (22-67) .”